Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma.
Davies FE, Raje N, Hideshima T, Lentzsch S, Young G, Tai YT, Lin B, Podar K, Gupta D, Chauhan D, Treon SP, Richardson PG, Schlossman RL, Morgan GJ, Muller GW, Stirling DI, Anderson KC.
Davies FE, et al. Among authors: podar k.
Blood. 2001 Jul 1;98(1):210-6. doi: 10.1182/blood.v98.1.210.
Blood. 2001.
PMID: 11418482
Free article.